Nadav Kidron - Net Worth and Insider Trading

Nadav Kidron Net Worth

The estimated net worth of Nadav Kidron is at least $3 Million dollars as of 2024-12-29. Nadav Kidron is the President and CEO of Oramed Pharmaceuticals Inc and owns about 1,179,098 shares of Oramed Pharmaceuticals Inc (ORMP) stock worth over $3 Million. Details can be seen in Nadav Kidron's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nadav Kidron has not made any transactions after 2023-03-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Nadav Kidron

To

Nadav Kidron Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nadav Kidron owns 1 companies in total, including Oramed Pharmaceuticals Inc (ORMP) .

Click here to see the complete history of Nadav Kidron’s form 4 insider trades.

Insider Ownership Summary of Nadav Kidron

Ticker Comapny Transaction Date Type of Owner
ORMP Oramed Pharmaceuticals Inc 2023-03-16 director & 10 percent owner

Nadav Kidron Latest Holdings Summary

Nadav Kidron currently owns a total of 1 stock. Nadav Kidron owns 1,179,098 shares of Oramed Pharmaceuticals Inc (ORMP) as of March 16, 2023, with a value of $3 Million.

Latest Holdings of Nadav Kidron

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ORMP Oramed Pharmaceuticals Inc 2023-03-16 1,179,098 2.37 2,794,462

Holding Weightings of Nadav Kidron


Nadav Kidron Form 4 Trading Tracker

According to the SEC Form 4 filings, Nadav Kidron has made a total of 4 transactions in Oramed Pharmaceuticals Inc (ORMP) over the past 5 years, including 2 buys and 2 sells. The most-recent trade in Oramed Pharmaceuticals Inc is the acquisition of 26,000 shares on March 16, 2023, which cost Nadav Kidron around $53,040.

Insider Trading History of Nadav Kidron

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nadav Kidron Trading Performance

GuruFocus tracks the stock performance after each of Nadav Kidron's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nadav Kidron is 31.7%. GuruFocus also compares Nadav Kidron's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nadav Kidron within 3 months outperforms 5 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Nadav Kidron's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Nadav Kidron

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
5 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 20.22 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 18.04 LIMIT LIMIT LIMIT LIMIT LIMIT

Nadav Kidron Ownership Network

Ownership Network List of Nadav Kidron

No Data

Ownership Network Relation of Nadav Kidron

Insider Network Chart

Nadav Kidron Owned Company Details

What does Oramed Pharmaceuticals Inc do?

Who are the key executives at Oramed Pharmaceuticals Inc?

Nadav Kidron is the director & 10 percent owner of Oramed Pharmaceuticals Inc. Other key executives at Oramed Pharmaceuticals Inc include Chief Commercial Officer Michael Rabinowitz , Chief Financial Officer David Silberman , and Chief Legal Officer Netanel Derovan .

Oramed Pharmaceuticals Inc (ORMP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Oramed Pharmaceuticals Inc (ORMP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oramed Pharmaceuticals Inc (ORMP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Oramed Pharmaceuticals Inc (ORMP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Oramed Pharmaceuticals Inc Insider Transactions

No Available Data

Nadav Kidron Mailing Address

Above is the net worth, insider trading, and ownership report for Nadav Kidron. You might contact Nadav Kidron via mailing address: 142 W. 57th St., New York Ny 10019.

Discussions on Nadav Kidron

No discussions yet.